We would like to thank our readers, subscribers and collaboration partners for a fruitful first quarter 2023, and we wish you all a relaxing Easter!
Until next week, here are some holiday reading, Editor’s picks:
The critical role of Nordic CDMOs
Contract development and manufacturing organizations are emerging as global key players within the pharmaceutical industry, and their Nordic presence and offering will give the region both resilience and a global competitive edge. Learn more about the history of Nordic CDMOs, strategic M&As and novel modalities, one-stop-shop services, pre-COVID conditions and opportunities, finding talent and the Nordic CDMO USP.
Making an Impact – in Business and in Society
Iris Öhrn considers herself a cosmopolitan person, and with good reason. The investment advisor for life science at Business Region Göteborg left her native Cuba to study and work abroad before settling in Sweden. While up until recently, most of Iris Öhrn’s goals were professional, now she is seeking to have more of an impact on greater society, by helping all people feel like they are included and contributing to the world.
Icelandic study changes the definition of multiple myeloma precursor condition
Findings from the major study iStopMM has been used to redefine monoclonal gammopathy of undetermined significance (MGUS), a precursor to multiple myeloma. Howard Bennett spoke with Þórir Einarsson Long, one of the authors, about the purpose of the study, and how it can help in cancer screening.
Good news for chocolate lovers?
Few people can resist chocolate. That’s why a paper from US, Canadian, and Danish scientists in Heart 2017, from the British Medical Journal group, was hailed as good news. The study showed that regularly eating chocolate might reduce risk of atrial fibrillation (AF), which is an irregular heartbeat. Chris Tachibana interviewed Professor Kim Overvad, Department of Public Health, Aarhus University, and Aalborg University Hospital, the paper’s senior author.
